Clearance Summary
HemosIL Factor XII Deficient Plasma received FDA 510(k) clearance under submission number K180486, sponsored by Instrumentation Laboratory CO. The device was reviewed via the Special premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 2018-03-22.
- Submission: K180486
- Applicant / Sponsor: Instrumentation Laboratory CO
- Clearance pathway: Special
- Review panel: Hematology
- Device class: Class II
- Regulation citation: 21 CFR 864.7290
- Decision date: 2018-03-22
Classification & Regulation
This clearance is catalogued under FDA product code GJT and 21 CFR 864.7290, within the Hematology review panel as a Class II device.